ANDOVER, Mass., May 02, 2018 -- Omnify Software, a leading provider of web-based Product Lifecycle Management (PLM) software for discrete manufacturers, along with their client, BionX Medical, now Ottobock, the leading global supplier of mechatronic prosthetic and orthotic devices, has been selected as a finalist for the 2018 Medical Design Excellence Awards (MDEA) for the design and development of the Empower prosthetic foot.
Now in its 20th year, the MDEA is the premier awards program for the medtech industry. The awards program celebrates the accomplishments of medical device manufacturers, their suppliers, and the many people behind the scenes—engineers, scientists, designers, and clinicians—who are responsible for the cutting-edge products that are saving lives. They are improving patient healthcare and transforming medtech—one innovation at a time. Omnify was recognized as Ottobock’s PLM supplier helping the company meet time to market, compliance and efficiency goals for a major re-design of the world’s only active prosthetic foot. The Empower is an innovation in the field of prosthetic feet and is equipped with an active ankle joint, making it the only prosthetic foot with powered propulsion.
"We are honored to be recognized for the MDEA alongside our customer," stated Chuck Cimalore, CTO for Omnify Software. "A growing number of medtech companies have adopted our PLM solution to help design safe, innovative, and compliant products and it is great to see our customers recognized for their product achievements."
The 2018 winners will be announced at the MDEA Ceremony on Tuesday, June 12, 2018 in conjunction with the MD&M East event, organized by UBM, taking place at the Jacob K. Javits Convention Center in New York. To learn more about the event please visit: www.MDMeast.com
About Omnify Software
Omnify Software, the leading provider of business-ready Product Lifecycle Management (PLM) solutions for discrete manufacturers, helps OEMs shorten development cycles, accelerate product innovation and improve bottom-line profitability. Omnify's commitment to customer success has resulted in a unique solution that is quick to implement, easy to use, and provides an open integration platform to easily share data with engineering and business systems. Our web-based technology offers flexible deployment options that allow customers to deploy on-premises, in the cloud or via a hybrid approach. Omnify is well-known for superior customer service, delivering outstanding training, development and support with a team of experienced technology professionals. For more information about Omnify Software Product Lifecycle Management, please call 978-988-3800, email [email protected], visit www.omnifysoft.com, or follow us on LinkedIn, Twitter, Facebook or YouTube.
About Ottobock
Ottobock Healthcare develops and pioneers medical technology products and treatment concepts for people with limited mobility in the areas of Prosthetics, Orthotics, Human Mobility (wheelchairs, rehabilitation devices) and MedicalCare. With subsidiaries in more than 50 countries, Ottobock offers “Best in Class” quality worldwide, and employs more than 7,000 team members. A family-managed company since its founding in 1919, Ottobock has also been supporting the Paralympic Games with its technical expertise since 1988.
"Omnify" is a registered trademark of Omnify Software. Any trade, product or service name referenced in this document using the name "Omnify" is a trademark and/or property of Omnify Software. All other trade, product, or service names referenced in this release may be trademarks or registered trademarks of their respective holders.”
Media Contact:
Alaine Portnoy
Omnify Software
[email protected]
978-988-3800
Valerie Harding
Ripple Effect Communications
[email protected]
617-536-8887


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



